ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER+ breast cancer.
Liang J, Yao X, Aouad P, Wang BE, Crocker L, Chaudhuri S, Liang Y, Darmanis S, Giltnane J, Moore HM, Aimi J, Chang CW, Gates MR, Eng-Wong J, Hafner M, Metcalfe C.
Liang J, et al. Among authors: chang cw.
Nat Cancer. 2025 Jan 13. doi: 10.1038/s43018-024-00898-8. Online ahead of print.
Nat Cancer. 2025.
PMID: 39805955